Jun 15, 2020
Mymee Appoints Melinda Decker as Chief Commercial Officer
Jun 04, 2020
Artax Biopharma Announces Series B Financing Extension to Advance First-in-Class Autoimmune Disease Therapy
May 29, 2020
Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors During 2020 Virtual European Congress of Rheumatology (EULAR 2020)
May 27, 2020
Q32 Bio Launches to Develop Novel Therapeutics Targeting Regulators of Innate and Adaptive Immunity
May 19, 2020
Autoimmune Disease Diagnostics Market Study, 2015-2025 Featuring Profiles of Leading Players Including Siemens, Abbott, Bio-Rad Labs, Pfizer, and Johnson & Johnson
May 13, 2020
Artax Biopharma Appoints Joseph Lobacki as Chief Executive Officer, Announces Expanded Management Team
May 12, 2020
Novel CAR NK-cell technology could lead to new treatments for lupus, other incurable diseases
May 12, 2020
Celiac Disease Linked to Common Chemical Pollutants
Apr 30, 2020
Provention Bio to Report First Quarter 2020 Financial Results and Host Conference Call on Thursday, May 7, 2020
Apr 21, 2020
Harbour BioMed Announces First Patient Dosing of Phase 1b/2a Study of Anti-FcRn Batoclimab for Treating Neuromyelitis Optica Spectrum Disorder
Apr 20, 2020
The global autoimmune disease diagnosis market size is projected to reach USD 6.3 billion by 2025 from USD 4.1 billion in 2020, at a CAGR of 8.9%
Apr 17, 2020
SAB Biotherapeutics Advances Therapeutic for COVID-19 in Partnership with Department of Defense and BARDA
Apr 15, 2020
FDA Grants Fast Track Designation to RemeGen's Telitacicept as a Treatment for Systemic Lupus Erythematosus
Apr 10, 2020
Early Impacts of COVID-19 on Autoimmune Disease Diagnosis Market - Exclusive Report by MarketsandMarkets(TM)
Mar 31, 2020
SAB Biotherapeutics Awarded $27M Contract to Develop Novel Rapid Response Capability for U.S. Department of Defense
Mar 30, 2020
The Global Autoimmune Disease Diagnostics Market is expected to grow by USD 1.94 bn during 2020-2024, progressing at a CAGR of 9% during the forecast period
Mar 27, 2020
6 Keys to Boosting Your Immune System During COVID-19
Mar 24, 2020
Chipscreen Biosciences's Original New Drug CS12192: Investigational New Drug (IND) Application Accepted
Mar 04, 2020
Mallinckrodt Announces Publication of New Data on Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis, Systemic Lupus Erythematosus and Dermatomyositis/Polymyositis Published in Open Access Rheumatology: Research and Reviews
Feb 06, 2020
Sonoma Biotherapeutics launches with $40 million in Series A funding to advance regulatory T cell therapy in autoimmune and degenerative diseases